• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动机制与合并症的动态变化

Dynamics of Atrial Fibrillation Mechanisms and Comorbidities.

作者信息

Heijman Jordi, Linz Dominik, Schotten Ulrich

机构信息

Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University, 6200 MD Maastricht, The Netherlands; email:

Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands; email:

出版信息

Annu Rev Physiol. 2021 Feb 10;83:83-106. doi: 10.1146/annurev-physiol-031720-085307. Epub 2020 Oct 16.

DOI:10.1146/annurev-physiol-031720-085307
PMID:33064962
Abstract

Atrial fibrillation (AF) contributes to morbidity and mortality of millions of individuals. Its molecular, cellular, neurohumoral, and hemodynamic pathophysiological mechanisms are complex, and there is increasing awareness that a wide range of comorbidities can contribute to AF-promoting atrial remodeling. Moreover, recent research has highlighted that AF risk is not constant and that the temporal variation in concomitant conditions contributes to the complexity of AF dynamics. In this review, we provide an overview of fundamental AF mechanisms related to established and emerging comorbidities or risk factors and their role in the AF-promoting effects. We focus on the accumulating evidence for the relevance of temporally dynamic changes in these risk factors and the consequence for AF initiation and maintenance. Finally, we highlight the important implications for future research and clinical practice resulting from the dynamic interaction between AF risk factors and mechanisms.

摘要

心房颤动(AF)导致数百万个体发病和死亡。其分子、细胞、神经体液和血流动力学病理生理机制复杂,人们越来越意识到多种合并症可促成促进房颤的心房重构。此外,最近的研究强调房颤风险并非恒定不变,伴随疾病的时间变化导致房颤动态变化的复杂性。在本综述中,我们概述了与既定和新出现的合并症或风险因素相关的房颤基本机制及其在促进房颤效应中的作用。我们关注这些风险因素随时间动态变化的相关性以及对房颤起始和维持的影响的累积证据。最后,我们强调房颤风险因素与机制之间的动态相互作用对未来研究和临床实践的重要意义。

相似文献

1
Dynamics of Atrial Fibrillation Mechanisms and Comorbidities.心房颤动机制与合并症的动态变化
Annu Rev Physiol. 2021 Feb 10;83:83-106. doi: 10.1146/annurev-physiol-031720-085307. Epub 2020 Oct 16.
2
Electrical and structural remodeling: role in the genesis and maintenance of atrial fibrillation.电重构与结构重构:在心房颤动发生和维持中的作用
Prog Cardiovasc Dis. 2005 Nov-Dec;48(3):153-68. doi: 10.1016/j.pcad.2005.06.014.
3
Role of tumor necrosis factor alpha in the pathogenesis of atrial fibrillation: A novel potential therapeutic target?肿瘤坏死因子α在心房颤动发病机制中的作用:一个新的潜在治疗靶点?
Ann Med. 2015 Jun;47(4):316-24. doi: 10.3109/07853890.2015.1042030. Epub 2015 May 18.
4
Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression.心房颤动的发生、维持和进展的细胞和分子电生理学。
Circ Res. 2014 Apr 25;114(9):1483-99. doi: 10.1161/CIRCRESAHA.114.302226.
5
Pathophysiological mechanisms of atrial fibrillation: a translational appraisal.心房颤动的病理生理机制:转化评估。
Physiol Rev. 2011 Jan;91(1):265-325. doi: 10.1152/physrev.00031.2009.
6
Obesity and atrial fibrillation.肥胖与心房颤动。
Obes Rev. 2013 Nov;14(11):929-38. doi: 10.1111/obr.12056. Epub 2013 Jul 24.
7
Atrial remodeling and atrial fibrillation: recent advances and translational perspectives.心房重构与心房颤动:最新进展及转化医学视角。
J Am Coll Cardiol. 2014 Jun 10;63(22):2335-45. doi: 10.1016/j.jacc.2014.02.555. Epub 2014 Mar 19.
8
Atrial fibrillation: the role of hypoxia-inducible factor-1-regulated cytokines.心房颤动:缺氧诱导因子-1 调节细胞因子的作用。
Mol Cell Biochem. 2021 Jun;476(6):2283-2293. doi: 10.1007/s11010-021-04082-9. Epub 2021 Feb 11.
9
Atrial fibrosis underlying atrial fibrillation (Review).心房纤维化在心房颤动中的作用(综述)。
Int J Mol Med. 2021 Mar;47(3). doi: 10.3892/ijmm.2020.4842. Epub 2021 Jan 15.
10
Modifiable Risk Factors and Atrial Fibrillation.可改变的风险因素与心房颤动。
Circulation. 2017 Aug 8;136(6):583-596. doi: 10.1161/CIRCULATIONAHA.116.023163.

引用本文的文献

1
An integrated bioinformatics approach for identification of key modulators and biomarkers involved in atrial fibrillation.一种用于识别参与心房颤动的关键调节因子和生物标志物的综合生物信息学方法。
J Cardiovasc Thorac Res. 2025 Jun 28;17(2):109-120. doi: 10.34172/jcvtr.025.33347. eCollection 2025 Jun.
2
Targeting the Substrate: Mechanism-Based Ablation Strategies for Persistent Atrial Fibrillation.靶向底物:持续性心房颤动基于机制的消融策略
J Clin Med. 2025 Jul 20;14(14):5147. doi: 10.3390/jcm14145147.
3
Challenges and Opportunities for Atrial Fibrillation Management.
心房颤动管理的挑战与机遇
Cardiol Discov. 2025 Jun;5(2):149-161. doi: 10.1097/CD9.0000000000000155. Epub 2025 Apr 10.
4
Factor XI/XIa inhibitors versus direct oral anticoagulants in atrial fibrillation with stroke risk: a GRADE-assessed meta-analysis of randomized controlled trials.在有卒中风险的心房颤动中,XI因子/XIa因子抑制剂与直接口服抗凝剂的比较:一项采用GRADE评估的随机对照试验的荟萃分析
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 16. doi: 10.1007/s00210-025-04259-9.
5
Practical Compendium of Antiarrhythmic Drugs: A Clinical Consensus Statement of the European Heart Rhythm Association of the ESC.抗心律失常药物实用手册:欧洲心脏病学会(ESC)欧洲心律协会临床共识声明
Europace. 2025 Mar 30. doi: 10.1093/europace/euaf076.
6
Multimorbidity Is Associated With Symptom Severity and Disease Progression in Patients with Paroxysmal Atrial Fibrillation-Data From the RACE V Study.多重疾病与阵发性心房颤动患者的症状严重程度和疾病进展相关——来自RACE V研究的数据。
J Am Heart Assoc. 2025 Mar 4;14(5):e034514. doi: 10.1161/JAHA.123.034514. Epub 2025 Feb 26.
7
Sarcopenia and Insulin Resistance Collective Effect on Atrial Fibrillation Risk: A Non-Diabetic Elderly Cohort Study.肌肉减少症和胰岛素抵抗对心房颤动风险的综合影响:一项非糖尿病老年队列研究。
J Cachexia Sarcopenia Muscle. 2025 Feb;16(1):e13736. doi: 10.1002/jcsm.13736.
8
Global, regional, and national burden of atrial fibrillation and atrial flutter from 1990 to 2021: sex differences and global burden projections to 2046-a systematic analysis of the Global Burden of Disease Study 2021.1990年至2021年全球、区域和国家心房颤动和心房扑动负担:性别差异及到2046年的全球负担预测——全球疾病负担研究2021的系统分析
Europace. 2025 Feb 5;27(2). doi: 10.1093/europace/euaf027.
9
Atrial Fibrosis in Atrial Fibrillation: Mechanistic Insights, Diagnostic Challenges, and Emerging Therapeutic Targets.心房颤动中的心房纤维化:机制洞察、诊断挑战及新兴治疗靶点
Int J Mol Sci. 2024 Dec 30;26(1):209. doi: 10.3390/ijms26010209.
10
Evolution in electrophysiology 100 years after Einthoven: translational and computational innovations in rhythm control of atrial fibrillation.在艾因托芬之后100年的电生理学进展:房颤节律控制中的转化与计算创新
Europace. 2024 Dec 26;27(1). doi: 10.1093/europace/euae304.